Significant Breakthrough in Late-Stage Urothelial Carcinoma Treatment: ADC Combined with Immunotherapy Significantly Prolongs Survival
This study was led by Professor Guo Jun and Professor Sheng Xi Nan from Peking University Cancer Hospital, and the results have been published in the prestigious international journal The New England Journal of Medicine, and presented at the European Society for Medical Oncology (ESMO) conference. Core Efficacy Data: Significant Extension of Survival This study … Read more
